HomeAI · summaries
Storia in 5 fonti
New weekly diabetes jab cuts blood sugar, body weight in major trial
New weekly diabetes jab retatrutide cuts blood sugar and drives double-digit weight loss in type 2 diabetes patients in major phase 3 trial, The Lancet reports.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Retatrutide benefits in obesity, type 2 diabetes ‘quite staggering’
NEW ORLEANS —A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an extent not seen with previous pharmacotherapy options,…
- ·
theguardian.com
Weekly diabetes jab shown to reduce blood-sugar levels and body weight
Experts say results from trial of new triple hormone drug for type 2 diabetes are striking but further tests needed
- ·
gulfnews.com
New weekly diabetes jab cuts blood sugar, body weight in major trial
New weekly diabetes jab retatrutide cuts blood sugar and drives double-digit weight loss in type 2 diabetes patients in major phase 3 trial, The Lancet reports.
- ·
medpagetoday.com
Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
But its key advantage is in its weight reduction abilities
- ·
newsbytesapp.com
This triple-action jab can lower your blood sugar and weight
A new triple-action weekly injection, retatrutide, has demonstrated significant reductions in blood sugar and body weight during phase 3 clinical trials.